Royal London Asset Management Ltd. Buys 15,589 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Royal London Asset Management Ltd. increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 8.8% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 192,026 shares of the company’s stock after acquiring an additional 15,589 shares during the quarter. Royal London Asset Management Ltd.’s holdings in GE HealthCare Technologies were worth $15,013,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of GEHC. Thrivent Financial for Lutherans increased its stake in GE HealthCare Technologies by 16.5% during the 3rd quarter. Thrivent Financial for Lutherans now owns 25,408 shares of the company’s stock valued at $2,385,000 after purchasing an additional 3,602 shares in the last quarter. Pathstone Holdings LLC increased its stake in GE HealthCare Technologies by 3.2% during the 3rd quarter. Pathstone Holdings LLC now owns 33,820 shares of the company’s stock valued at $3,174,000 after purchasing an additional 1,063 shares in the last quarter. Prospera Financial Services Inc increased its stake in GE HealthCare Technologies by 5.3% during the 3rd quarter. Prospera Financial Services Inc now owns 5,014 shares of the company’s stock valued at $471,000 after purchasing an additional 253 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in GE HealthCare Technologies during the 3rd quarter valued at $1,396,000. Finally, Avior Wealth Management LLC increased its stake in GE HealthCare Technologies by 13.9% during the 3rd quarter. Avior Wealth Management LLC now owns 3,871 shares of the company’s stock valued at $363,000 after purchasing an additional 472 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on GEHC. The Goldman Sachs Group raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th. Wells Fargo & Company lifted their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. Citigroup lifted their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. Finally, Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $98.75.

GE HealthCare Technologies Price Performance

NASDAQ GEHC opened at $81.49 on Friday. The company has a market cap of $37.27 billion, a PE ratio of 18.82, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. GE HealthCare Technologies Inc. has a 52 week low of $74.51 and a 52 week high of $94.80. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The firm’s 50-day simple moving average is $87.02 and its two-hundred day simple moving average is $86.03.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. Research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.